SFX by Ex Libris Inc.

Title:	Quantitative Determination by 14C Analysis of the Biological Component in Fuels
Source:	Radiocarbon [0033-8222] Dijs, Ivo yr:2006

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Norton, Glenn A. "Simplified Radiocarbon Analysis Procedure for Measuring the Renewable Diesel Concentration in Diesel Fuel Blends." Journal of the American Oil Chemists' Society 89.5 (2012): 797-803.
description	2.	Lappin, G. "Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs." Clinical pharmacology and therapeutics 80.3 (2006): 203-215.
description	3.	Omoto, K. "A high precision Î²-counting method of biomass samples by Quantulus 1220 LSC." 日本大学文理学部自然科学研究所研究紀要 46 (2011): 397-.
description	4.	Aptula, Aynur O O. "Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity." Chemical research in toxicology 19.8 (2006): 1097-105.
description	5.	Klem, B. "Determination of the bioavailability of [C-14]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers." The Journal of clinical pharmacology 46.4 (2006): 456-460.
description	6.	Gueorguieva, I. "Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs." Journal of Pharmacokinetics and Pharmacodynamics 33.5 (2006): 571-594.
description	7.	Saari, Teijo I I. "Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam." Clinical pharmacology and therapeutics 79.4 (2006): 362-70.
description	8.	Hovhannisyan, A.S. S. "The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats." Phytomedicine 13.5 (2006): 318-323.
description	9.	Leaney, F. "The direct absorption method of (super 14) C assay-historical perspective and future potential." Quaternary science reviews 25.9-10 (2006): 1073-1079.
description	10.	Panossian, A. "Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats." Phytotherapy research 23.3 (2009): 351-357.
description	11.	Gueorguieva, I. "Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios." Journal of pharmacokinetics and pharmacodynamics 31.4 (2004): 269-298.
description	12.	Andersson, A. "14C-Based source assessment of soot aerosols in Stockholm and the Swedish EMEP-Aspvreten regional background site." Atmospheric environment 45.1 (2011): 215-222.
description	13.	David, David R. "Electrophilic Chemistry Related to Skin Sensitization. Reaction Mechanistic Applicability Domain Classification for a Published Data Set of 106 Chemicals Tested in the Mouse Local Lymph Node Assay." Chemical research in toxicology 20.1 (2007): 44-60.
description	14.	Hisaka, A. "Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information." Pharmacology & therapeutics 125.2 (2010): 230-248.
description	15.	Leclercq, L. "Which Human Metabolites Have We MIST? Retrospective Analysis, Practical Aspects, and Perspectives For Metabolite Identification and Quantification in Pharmaceutical Development." Chemical research in toxicology 22.2 (2009): 280-293.
description	16.	Bachelor, P. "Potential method for measurement of CO2 leakage from underground sequestration fields using radioactive tracers." Journal of radioanalytical and nuclear chemistry 277.1 (2008): 85-89.
description	17.	Holford, Bruce H. "Analysis of population pharmacokinetic data using NONMEM and WinBUGS." Journal of biopharmaceutical statistics 15.1 (2005): 53-73.
description	18.	Rodrigues, C. "Enterohepatic recirculation of norfloxacin - a whole body physiologically based pharmacokinetic model." Journal of Pharmacy and Pharmacology 57 (2005).
description	19.	Orlando, R. "Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine." Clinical pharmacology and therapeutics 79.5 (2006): 489-99.
description	20.	Lewis, Mark C C. "Change in liver size and fat content after treatment with Optifast very low calorie diet." Obesity Surgery 16.6 (2006): 697-701.